Top 10 Medical Device Angel Investors in Australia (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Andrew R Banks
Angel
|
1 | Australia | Seed | Grocery, Medical, Health Care | $300k–$950k |
|
Nicolas de Fontenay
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Michael Gregg
Angel
|
1 | Australia | Series A, Series B | Manufacturing, Dental, Fashion | $4.6M–$22M |
|
Amaury Cadet de Fontenay
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Li Ka-shing
Angel
|
1 | United States, United Kingdom, Israel | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $300k–$50M |
|
Allan Moss
Angel
|
1 | Australia, United States, The Netherlands | Series A, Seed | Health Care, Medical Device, Biotechnology | $2.3M–$8.8M |
|
Kat Dunn
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Wilson Wan
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Andy Huynh
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Benjamin Zwick
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
| Access all 17 angel investors in Australia Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Andrew R Banks
Show more...Investment focus
- Industry: Grocery, Medical, Health Care
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Seed $300k–$950k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
- Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.
Nicolas de Fontenay
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Mike started his career in retail, managing Nock & Kirby stores before completing his MBA. He was the GM of the paging business, Link Telecommunications (back when pagers were cool!), before leading a management buy-out of Health Communication Network (HCN) from the government in 1995. As MD, he saw it grow from no staff to an ASX listingduring the dotcom days.
Show more...Investment focus
- Industry: Manufacturing, Dental, Fashion
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 4
- Round size: Series A $4.7M–$22M; Series B $4.6M–$12M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Dentroid — Dentroid is a manufacturer and supplier of medical equipment for dental industry.
- BlockTexx — BlockTexx is an early stage clean technology company that recovers polyester and cellulose from textiles and clothing.Through an Australian developed patent pending process that combines chemical recovery technology and advanced manufacturing to produce high quality recycled materials of rPET pellets and cellulose powder from textile waste.BlockTexx is positioned at the end of the value chain, where raw materials and end-of-use solutions have the highest environmental impact and revenue potential.
- GPN Vaccines — GPN Vaccines are a type of vaccine that is used to prevent the spread developing a vaccine against streptococcus pneumoniae.
Amaury Cadet de Fontenay
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Mr. Li Ka-shing is the richest person of East Asian descent in the world and the 11th richest person in the world with an estimated wealth of US$26 billion (as estimated by Forbes). His primary operating company is Hutchison Whampoa Limited. Mr Li's younger son, Richard, is Chairman of PCCW, one of Asia's leading internet andtelecommunications companies.Mr Li Ka-shing is the Chairman of Cheung Kong (Holdings) Limited and Hutchison Whampoa Limited. Cheung Kong (Holdings) Limited is the flagship of the Cheung Kong Group which has business operations in 54 countries around the world and employs about 240,000 staff. In Hong Kong alone, the Group includes nine listed companies with a combined market capitalization of approximately HKD600 billion (30 June 2009). Hutchison Whampoa Limited is a Fortune Global 500 company.Born in 1928 in Chiu Chow, a coastal city in the southeastern part of China, Mr Li fled to Hong Kong with his family to avoid the perils of war. His father suffered from tuberculosis and passed away in Hong Kong. Shouldering the responsibility of looking after the livelihood of the family, Mr Li was forced to leave school before the age of 15 and found a job in a plastics trading company where he labored 16 hours a day. By 1950, his hard work, prudence and his pursuit of excellence had enabled him to start his own company, Cheung Kong Industries. From manufacturing plastics, Mr Li led and developed his company into a leading real estate investment company in Hong Kong that was listed on the Hong Kong Stock Exchange in 1972. Cheung Kong continued to expand by acquiring Hutchison Whampoa and Hongkong Electric Holdings Limited in 1979 and 1985 respectively.Based in Hong Kong, the Cheung Kong Group's businesses encompass such diverse areas as property development and investment, real estate agency and estate management, hotels, telecommunications and e-commerce, finance and investments, retail, ports and related services, energy, infrastructure projects and materials, media, and biotechnology. Mr Li is a strong believer in synergy — the power of combined efforts. This belief is reflected in his naming his company Cheung Kong Holdings after the Yangtze River that flows through China, a great river that aggregates countless streams and tributaries. The Times in the United Kingdom and Ernst & Young UK jointly named Mr Li as the Entrepreneur of the Millennium at the turn of the century.http://www.hutchison-whampoa.com/eng/about/chairman/chairman.htm 30 June 2009
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 27
- Round size: Seed $300k–$11M; Series A $21M–$50M; Series B $15M–$50M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Omni — Omni aims to revolutionise mobility in cities and campuses by empowering residents with cleaner, more efficient, and affordable transportation options that improve urban sustainability in the United Kingdom. By systematically deploying thousands of smart-bikes, enabled with GPS, wireless technology, and self-locks, we will dramatically improveurban mobility by making the first and last mile faster, cheaper, and healthier. We take city and school friendly approach and seek for partnership to work on this challenging problem.
- Fertilis — Fertilis: A better way to care for your embryos in an IVF clinic. Fertilis technology involves each embryo growing inside its own patented micro-3D printed pod. The pod protects the embryo and enables automated subtle changes to the nutritive composition of the solutions that bathe the embryo.
- WELL Health Technologies — WELL aims to positively impact health outcomes by leveraging technology to empower and support patients and doctors. Learn about our mission and purpose.
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series A, Seed
- Geography: Australia, United States, The Netherlands
Investor stats
- Total investments: 9
- Round size: Series A $2.3M–$8.8M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — From inspection to insight. We build the Physical AI layer for industrial asset integrity. Get repeatable, decision-ready data and asset life analytics - without confined space entry
Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Wilson Wan
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Andy Huynh
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Benjamin Zwick
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Medical Device Angel investor funding in Australia at a glance
Stats across 12 deals from 17 investors.
Access all 17 angel investors in Australia Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Angel Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 17 angel investors investing in Australia Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
